Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,708 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized placebo-controlled study of the safety, tolerability, antiviral activity, and pharmacokinetics of 10-day monotherapy with BMS-986001, a novel HIV NRTI, in treatment-experienced HIV-1-infected subjects.
Cotte L, Dellamonica P, Raffi F, Yazdanpanah Y, Molina JM, Boué F, Urata Y, Chan HP, Zhu L, Chang I, Bertz R, Hanna GJ, Grasela DM, Hwang C. Cotte L, et al. Among authors: chang i. J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):346-54. doi: 10.1097/QAI.0b013e3182965d12. J Acquir Immune Defic Syndr. 2013. PMID: 23771104 Clinical Trial.
Evaluation of nasal septum deviation via reformatted computed tomography (CT) imaging following expansion using RPE and MARPE.
Schron D, Ran-Sukkawala M, Pereira E, Zhang Y, Hwang N, Chang IW, Lindquist K, Williams R, Peng J, Nedjat-Haiem M, Kang K, Hong C, Yoon A. Schron D, et al. Among authors: chang iw. J World Fed Orthod. 2024 Dec 20:S2212-4438(24)00089-4. doi: 10.1016/j.ejwf.2024.11.003. Online ahead of print. J World Fed Orthod. 2024. PMID: 39709256
Longer-term survival, quality of life, and cost-effectiveness of conservative versus liberal oxygenation targets in critically ill children: a pre-specified analysis from Oxy-PICU, a multicentre, open, parallel-group, randomised controlled trial.
Moler-Zapata S, Peters MJ, Gould DW, Giallongo E, Orzol M, Ray S, Thomas K, Chang I, O'Neill L, Agbeko R, Au C, Draper E, Elliot-Major L, Lampro L, Pappachan J, Peters S, Ramnarayan P, Rowan KM, Harrison DA, Mouncey PR, Sadique Z; Oxy-PICU Investigators of the Paediatric Critical Care Society Study Group (PCCS-SG). Moler-Zapata S, et al. Among authors: chang i. Lancet Child Adolesc Health. 2025 Jan;9(1):16-24. doi: 10.1016/S2352-4642(24)00294-3. Lancet Child Adolesc Health. 2025. PMID: 39701658 Free article. Clinical Trial.
Velmanase alfa approved for treatment of non-central nervous system manifestations of alpha-mannosidosis: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG).
Lander JM, Penon-Portmann M, Sutton VR, Chang I; ACMG Therapeutics Committee5∗documents@acmg.net. Lander JM, et al. Among authors: chang i. Genet Med Open. 2024 Apr 5;2:101832. doi: 10.1016/j.gimo.2024.101832. eCollection 2024. Genet Med Open. 2024. PMID: 39669629 Free PMC article. No abstract available.
1,708 results